Tandem Diabetes Care (TNDM) Asset Utilization Ratio (2014 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Asset Utilization Ratio came in at 0.9 in Q2 2026, down 19.0% on a YoY basis from 1.11 in Q2 2025, and down 10.64% quarter-over-quarter from 1.01 in Q1 2026.
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Asset Utilization Ratio (2014 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has reported Asset Utilization Ratio for 13 consecutive years, with 0.9 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Asset Utilization Ratio fell 19.0% year-over-year to 0.9; the trailing twelve-month figure through Jun 2026 stood at 0.9 (down 19.0% YoY), and the FY2025 full-year result was 1.1, up 12.1% from the prior year.
- Asset Utilization Ratio declined to 0.9 in Q2 2026 per TNDM's latest filing, from 1.01 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.16 in Q4 2025 and bottomed at 0.75 in Q2 2022.
- Historically, Asset Utilization Ratio has averaged 0.9 across 5 years, with a median of 0.84 in 2023.
- The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio soared 31.49% in 2025, then slipped 19.0% in 2026.
- Over 5 years, Asset Utilization Ratio stood at 0.76 in 2022, then advanced by 3.57% to 0.79 in 2023, then advanced by 23.6% to 0.98 in 2024, then increased by 18.35% to 1.16 in 2025, then dropped by 21.91% to 0.9 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.9, 1.01, and 1.16 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn | 0.42 |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn | 0.54 |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn | 0.40 |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn | 0.55 |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | 0.47 |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 0.48 |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | 0.34 |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn | 0.76 |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn | 0.56 |
| 10 | Tandem Diabetes Care | 1.27 Bn | 811.05 Mn | 144.78 Mn | 0.90 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.90 |
| Mar 31, 2026 | 1.01 |
| Dec 31, 2025 | 1.16 |
| Sep 30, 2025 | 1.15 |
| Jun 30, 2025 | 1.11 |
| Mar 31, 2025 | 1.04 |
| Dec 31, 2024 | 0.98 |
| Sep 30, 2024 | 0.90 |
| Jun 30, 2024 | 0.85 |
| Mar 31, 2024 | 0.81 |
| Dec 31, 2023 | 0.79 |
| Sep 30, 2023 | 0.82 |
| Jun 30, 2023 | 0.83 |
| Mar 31, 2023 | 0.79 |
| Dec 31, 2022 | 0.76 |
| Sep 30, 2022 | 0.76 |
| Jun 30, 2022 | 0.75 |
| Mar 31, 2022 | 0.77 |
| Dec 31, 2021 | 0.80 |
| Sep 30, 2021 | 0.80 |